Healthcare provider profile · identity verified

Christopher Joseph Lee, MD

Family Practice · SHAMOKIN DAM, PA · NPI 1215034020

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	497	140
Levothyroxine Sodium	Levothyroxine Sodium	343	84
Omeprazole	Omeprazole	295	89
Amlodipine Besylate	Amlodipine Besylate	286	66
Rosuvastatin Calcium	Rosuvastatin Calcium	267	74
Lisinopril	Lisinopril	220	65
Metoprolol Succinate	Metoprolol Succinate	217	58
Prednisone	Prednisone	195	71
Eliquis	Apixaban	190	36
Duloxetine Hcl	Duloxetine Hcl	189	61
Losartan Potassium	Losartan Potassium	186	49
Pantoprazole Sodium	Pantoprazole Sodium	171	50
Metformin Hcl	Metformin Hcl	161	47
Hydrochlorothiazide	Hydrochlorothiazide	159	43
Gabapentin	Gabapentin	142	51
Tamsulosin Hcl	Tamsulosin Hcl	142	41
Simvastatin	Simvastatin	124	24
Furosemide	Furosemide	118	34
Olmesartan Medoxomil	Olmesartan Medoxomil	114	32
Lorazepam	Lorazepam	110	32
Metformin Hcl Er	Metformin Hcl	110	34
Famotidine	Famotidine	98	24
Metoprolol Tartrate	Metoprolol Tartrate	98	26
Jardiance	Empagliflozin	96	28
Potassium Chloride	Potassium Chloride	94	26
Tramadol Hcl	Tramadol Hcl	88	21
Albuterol Sulfate Hfa	Albuterol Sulfate	86	48
Montelukast Sodium	Montelukast Sodium	86	20
Torsemide	Torsemide	86	27
Fluticasone Propionate	Fluticasone Propionate	85	40
Meloxicam	Meloxicam	81	33
Clopidogrel	Clopidogrel Bisulfate	79	25
Trazodone Hcl	Trazodone Hcl	79	20
Diclofenac Sodium	Diclofenac Sodium	75	34
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	72	72
Ozempic	Semaglutide	72	22
Pravastatin Sodium	Pravastatin Sodium	70	16
Sertraline Hcl	Sertraline Hcl	69	30
Bupropion Xl	Bupropion Hcl	68	17
Xarelto	Rivaroxaban	68	suppressed
Ezetimibe	Ezetimibe	67	23
Atenolol	Atenolol	64	21
Citalopram Hbr	Citalopram Hydrobromide	64	20
Escitalopram Oxalate	Escitalopram Oxalate	64	25
Allopurinol	Allopurinol	62	14
Fluoxetine Hcl	Fluoxetine Hcl	60	15
Doxycycline Hyclate	Doxycycline Hyclate	57	36
Glipizide	Glipizide	57	16
Venlafaxine Hcl Er	Venlafaxine Hcl	56	13
Xultophy 100-3.6	Insulin Degludec/Liraglutide	52	16
Triamcinolone Acetonide	Triamcinolone Acetonide	51	38
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	50	16
Finasteride	Finasteride	48	12
Isosorbide Mononitrate Er	Isosorbide Mononitrate	48	11
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	48	19
Cephalexin	Cephalexin	47	36
Warfarin Sodium	Warfarin Sodium	46	15
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	45	16
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	44	16
Rabeprazole Sodium	Rabeprazole Sodium	44	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	44	33
Chlorthalidone	Chlorthalidone	40	14
Glipizide Er	Glipizide	40	11
Estradiol	Estradiol	39	17
Bupropion Hcl	Bupropion Hcl	38	suppressed
Carvedilol	Carvedilol	38	13
Donepezil Hcl	Donepezil Hcl	37	suppressed
Buspirone Hcl	Buspirone Hcl	36	suppressed
Doxepin Hcl	Doxepin Hcl	36	11
Rybelsus	Semaglutide	34	suppressed
Wegovy	Semaglutide	34	suppressed
Alendronate Sodium	Alendronate Sodium	33	12
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	33	suppressed
Novolog Flexpen	Insulin Aspart	33	12
Pregabalin	Pregabalin	33	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	32	29
Multaq	Dronedarone Hcl	32	suppressed
Breo Ellipta	Fluticasone/Vilanterol	31	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	31	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	31	suppressed
Unifine Pentips	Pen Needle, Diabetic	31	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	30	suppressed
Oxycodone Hcl	Oxycodone Hcl	30	16
Felodipine Er	Felodipine	29	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	29	suppressed
Ipratropium Bromide	Ipratropium Bromide	28	14
Amoxicillin	Amoxicillin	27	21
Mirtazapine	Mirtazapine	27	15
Mupirocin	Mupirocin	27	27
Cefdinir	Cefdinir	26	13
Latanoprost	Latanoprost	25	suppressed
Alprazolam	Alprazolam	24	suppressed
Azithromycin	Azithromycin	24	18
Baclofen	Baclofen	24	13
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	24	suppressed
Hydralazine Hcl	Hydralazine Hcl	23	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	23	suppressed
Aripiprazole	Aripiprazole	22	suppressed
Ondansetron Odt	Ondansetron	22	suppressed
Spironolactone	Spironolactone	22	suppressed
Tradjenta	Linagliptin	22	suppressed
Memantine Hcl	Memantine Hcl	21	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	20	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	19	18
Nystatin	Nystatin	19	12
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	18	14
Valacyclovir	Valacyclovir Hcl	18	suppressed
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	17	17
Memantine Hcl Er	Memantine Hcl	17	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	17	suppressed
Repaglinide	Repaglinide	17	suppressed
Ulticare Pen Needle	Pen Needle, Diabetic	17	suppressed
Celecoxib	Celecoxib	16	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	16	16
Synthroid	Levothyroxine Sodium	16	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	15	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	15	suppressed
Spiriva Respimat	Tiotropium Bromide	15	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	14	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	14	suppressed
Nadolol	Nadolol	14	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	14	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	14	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	14	14
Temazepam	Temazepam	14	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Valsartan	Valsartan	14	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	14	suppressed
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	13	13
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	13	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	13	suppressed
Lansoprazole	Lansoprazole	13	suppressed
Mesalamine Dr	Mesalamine	13	suppressed
Roflumilast	Roflumilast	13	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	12	suppressed
Buprenorphine	Buprenorphine	12	suppressed
Clonazepam	Clonazepam	12	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	12	suppressed
Fluconazole	Fluconazole	12	suppressed
Glimepiride	Glimepiride	12	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	12	suppressed
Solifenacin Succinate	Solifenacin Succinate	12	suppressed
Azelastine-Fluticasone	Azelastine/Fluticasone	11	suppressed
Bupropion Hcl Sr	Bupropion Hcl	11	suppressed
Cefpodoxime Proxetil	Cefpodoxime Proxetil	11	suppressed
Cilostazol	Cilostazol	11	suppressed
Cyclosporine	Cyclosporine	11	suppressed
Enalapril Maleate	Enalapril Maleate	11	suppressed
Mounjaro	Tirzepatide	11	suppressed
Repatha Syringe	Evolocumab	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error